Related Experiment Video
Updated: Aug 18, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
[Epidemiology of HPV infection]
J-C Boulanger1, H Sevestre, E Bauville
1Centre de gynécologie obstétrique, CHU, 124, rue Camille-Desmoulins, 80054 Amiens, France. boulanger.jean-charles@chu-amiens.fr
Abstract:
HPV DNA testing using Hybrid Capture 2 (Digene) was added to a program of liquid based (Thinprep, Cytyc) cervical cancer screening in a population of sexually active women aged from 20 to 62 years, without the history of uterine cervix pathology. 14.32% of 3832 women in this population were HPV positive. Positivity peaked in women aged 25-29 (19.4%) and gradually decreased, with 8% of positivity after 60 years. Positivity was independently related to parity, tobacco use and was correlated to cervical pathology. The rate of positivity in this population seems to preclude the use of HPV testing as a primary screening tool.
Related Concept Videos
Cancer Prevention
Some...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Herpes
Chickenpox
Poliomyelitis
Genital Herpes

